Hera Health, a pioneering women's healthcare company, today announced acceptance to present a "late-breaking" study on pregnancy risk assessment at the Society for Maternal-Fetal Medicine 2025 Pregnancy Meetingâ„¢.
LAS VEGAS, Dec. 13, 2024 /PRNewswire-PRWeb/ -- Hera Health, a pioneering women's healthcare company, today announced acceptance to present a "late-breaking" study on pregnancy risk assessment at the Society for Maternal-Fetal Medicine 2025 Pregnancy Meetingâ„¢.
The Big Idea: Precision in Pregnancy Care
Dr. Brian Iriye, President of Hera Health and maternal-fetal medicine expert at the High Risk Pregnancy Center will present research results from the .
Why It Matters
Preterm birth remains a significant healthcare challenge:
- More than 1 in 10 infants born prematurely in the United States
- Potential long-term medical complications for women and children
- Estimated $25 billion in annual healthcare costs related to prematurity
Conference Information
The Pregnancy Meetingâ„¢ is an annual conference that brings together researchers and medical professionals in the field of maternal-fetal medicine.
About Hera Health
Hera Health is dedicated to advancing women's healthcare through innovative diagnostic and precision medicine approaches. Our mission is to empower healthcare providers with cutting-edge tools to improve maternal and neonatal health outcomes.
For more information, email [email protected] or visit .
Media Contact
Mike McCleney, Hera Women's Health, 1 617-543-3444, [email protected],
SOURCE Hera Women's Health
Share this article